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Abstract: Posterior scleritis is a rare underdiagnosed condition that can potentially cause 
  blindness. Its varied presentations lead to delayed or incorrect treatment. We present here the 
cases of two patients with nodular posterior scleritis mimicking a choroidal metastasis. Two 
female patients presented with a sudden unilateral visual loss associated with ocular pain. Fundus 
examination revealed temporomacular choroidal masses with exudative detachments that, due 
to angiographic presentation, were suggestive of choroidal metastasis. Systemic examinations 
were unremarkable. In the two cases, a local or general anti-inflammatory treatment led to 
the complete recovery of the lesions, which were, thus, considered nodular posterior scleritis. 
The diagnosis of nodular posterior scleritis has to be evoked in all patients presenting with a 
choroidal mass in fundus examination. It represents the principal curable differential diagnosis 
of malignant choroidal tumor.
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Introduction
Posterior scleritis is often misdiagnosed due to its low incidence. This inflammatory 
condition of the eye wall can concern the whole sclera in its diffuse form or involve 
only a part of it in its nodular presentation. Nodular posterior scleritis (NPS) can 
simulate a choroidal tumor. A few cases have been reported showing the difficulty in 
differentiating these two conditions and to introduce an appropriate treatment. We report 
here the cases of two female patients who were initially diagnosed with a choroidal 
metastasis and who healed with an anti-inflammatory treatment.
Case presentation
Case 1
A 38-year-old Afro-Caribbean woman was referred to our center with sudden visual 
loss associated with ocular pain. She had no significant medical history. Local treat-
ment had already been introduced. It consisted of corticosteroid drops associated with 
mydriatics. The patient felt a slight improvement, but the pain recurred and the acuity 
decreased considerably. Best-corrected visual acuity was 20/80 in the right eye and 
20/20 in the left eye. There was no ocular redness. Anterior segment was   unremarkable. 
Funduscopic examination of the right eye revealed a single yellowish choroidal mass 
temporal to the macula associated with an exudative detachment in the inferior retina 
(Figure 1). Fluorescein angiography (FA) exhibited an early heterogenous hyperfluo-
rescence (Figure 2). B-scan ultrasonography showed a   dome-shaped mass with fluid Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Figure 1 Case 1. Fundus photograph. Massive yellowish lesion, temporal to fovea, 
with an exudative detachment involving the fovea and choroidal folds.
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Figure 2 Case 1. Fluorescein angiography sequence. Pronounced choroidal folds 
and early hyperfluorescence, with leakage and some pin points.
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Figure 3 Case 1. B-scan ultrasonography. Thickening of the ocular coats associated 
with subretinal fluid adjacent to the mass (A). There is no orbital shadowing. Mass 
was prominent in the vitreous cavity and measured 11 mm × 4.6 mm (B).
Figure 4 Case 2. Fundus photograph. Unique and massive orange-yellow protruding 
lesion temporal to macula with an exudative detachment involving the fovea and 
extending inferiorly.
in the subretinal space (Figure 3). With the   exception of the 
mass that was prominent in the vitreous cavity,   measuring 
11 mm × 4.6 mm, sclera had a normal aspect. There was 
no orbital shadowing. Blood tests highlighted an isolated 
inflammatory syndrome with an accelerated sedimentation 
rate (98 mm the first hour) but complete blood cell count, 
rheumatoid factor, angiotensin converting enzyme, and 
antinuclear antibodies were normal. Oncologic examination 
showed no evidence for a systemic malignancy. The patient 
underwent brain magnetic resonance imaging (MRI), body-
scan, mammography, thyroid ultrasonography, gastroscopy, 
and positron emission tomography scan. Based on the clini-
cal and radiological evaluations, the diagnosis of NPS was 
made. Oral corticotherapy was initiated, and the patient 
was   monitored 3 weeks later. Visual acuity in the right eye 
improved to 20/40 and the fundus examination no longer 
showed abnormalities. The patient stopped her treatment 
4 weeks later. Visual acuity then continued to improve to 
20/20. She did not experience any recurrence of the symp-
toms in the subsequent 2 years.
Case 2
A 52-year-old woman presented with sudden visual loss in the 
right eye. She experienced ocular pain and unusual headache for 
1 month before the visual impairment. She had no significant 
medical history, but one of her sisters had died of breast cancer. 
Her visual acuity was 20/200 in the right eye and 20/20 in the 
left eye. There were no abnormalities in her anterior segments. 
Right fundus examination exhibited a unique and massive 
yellowish lesion temporal to fovea with an exudative detach-
ment involving the fovea and extending inferiorly (Figure 4). 
There were no vitreous cells. FA highlighted a progressive 
and heterogeneous hyperfluorescence during the sequence and 
pin points. There was no dual circulation (Figure 5). Optical 
coherence tomography examination highlighted serous sub-
retinal fluid surrounding an elevation of the retina (Figure 6). 
The patient was treated with nonsteroidal anti-inflammatory 
eye drops and underwent a general and oncologic evalua-
tion. Brain MRI showed a high-signal dome-shaped lesion Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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to the relatively frequent association of anterior segment 
involvement.2 However, our patients reported ocular pain 
but did not show any ocular redness.
At fundus examination, the nodular inflammatory lesion 
cannot be distinguished from a choroidal metastasis or an 
achromic melanoma; so much so that some patients have 
undergone enucleation.3 Nevertheless, some clinical signs can 
help with the diagnosis. The association with anterior   scleritis, 
a serous retinal detachment and, more seldom, a   papillary 
edema are suggestive of an inflammatory condition.
The key for diagnosis is probably the B-scan   ultrasonography. 
In NPS, there is a thickening of the sclera and a diffuse hyper-
echogenicity of the mass without orbital shadowing, unlike 
melanoma or metastasis, which are both characterized by a 
moderate hyperechogenicity or a hypoechogenicity. Presence of 
fluid next to the dome-shaped mass explains the low visual acu-
ity in our first patient (Figure 3A) and is furthermore an argu-
ment for the inflammatory etiology. In both tumors and NPS, 
FA reveals pin points in the lesion area, but the presence of a 
dual circulation is a strong argument for a choroidal   melanoma. 
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Figure 5 Case 2. Fluorescein angiography sequence. Progressive and heterogeneous 
hyperfluorescence, with pin points temporal to the mass.
Figure 6 Case 2. Optical coherence tomography. serous retinal detachment and 
elevation of the retina depending on a choroidal mass.
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Figure  7  Case  2.  Brain  magnetic  resonance  imaging  in  FLAIR  (fluid-attenuated 
inversion  recovery  sequence)  (A),  T1  weighted  with  gadolinium  (B)  and  sTIr 
(short-tau inversion recovery sequence) (C). The nodular lesion appears in well 
limited hypersignal in the right eye, with no gadolinium enhancement. The hypersignal 
is most prominent in the sTIr sequence.
on fluid-attenuated inversion recovery sequences (Figure 7). 
Two weeks later, while the radiological evaluation was initi-
ated, she reported an improvement in visual acuity. Fundus 
examination was surprisingly normal. Neither retinal lesion 
nor serous detachment was observed. FA showed a punctuated 
hyperfluorescence in place of the initial lesion, suggesting 
retinal pigment epithelium atrophy (Figure 8). No general 
inflammatory disease was found. The patient did not experi-
ence any other recurrence in the subsequent 5 months.
Discussion
Diffuse and nodular posterior scleritis share the same etiolo-
gies than anterior orbital inflammations (the most common 
is Wegener’s granulomatosis) when they are not idiopathic.1 
No inflammatory etiology was found in our two patients, 
despite the isolated biological inflammatory syndrome of the 
first one which cleared up spontaneously.
Clinically, pain is the symptom that leads to considering 
a possible inflammatory disease. Indeed, choroidal tumors 
are indolent as a rule. Hatef et al ascribes this functional sign 
Figure 8 Case 2. Fluorescein angiography 2 weeks after the first examination. 
Punctuated hyperfluorescence in place of the initial lesion, suggesting retinal pigment 
epithelium atrophy.Clinical Ophthalmology
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If a biopsy is undergone, the sclera can appear thickened and 
infiltrated with inflammatory cells. Granulomatous reaction 
and areas of necrosis can also be observed.3
Corticotherapy led to a total recovery of the symptoms in 
our first patient, while the lesion of the second disappeared 
with nonsteroid anti-inflammatory drops. Previous reports 
of NPS show a favorable evolution in most cases, but the 
aggressiveness of the treatments used is very heterogeneous. 
Indeed, Demirci reports a 12-year follow-up of giant NPS 
stabilizing without treatment.4 Other authors report the use of 
high-dose intravenous corticotherapy, which can be associ-
ated with immunosuppressive drugs.2,5
In a large series of posterior scleritis, McCluskey et al1 
used systemic corticosteroids and immunosuppressive therapy 
when patients presented visual loss, optic nerve involvement, 
or associated systemic diseasess. Idiopathic scleritis would 
favorably respond to a local nonsteroid anti-inflammatory 
treatment as in the case of our second patient.
Conclusion
The scarcity of NPS does not allow a specific care protocol 
to be established. Decreased visual acuity justifies a general 
anti-inflammatory treatment, which may be considered as a 
therapeutic test. It is thus suitable to evoke this diagnosis in 
all cases of choroidal tumor, especially when the patient is a 
female with no evidence for a general neoplastic disease.
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